COP — CompuGroup Medical SE & Co KgaA Share Price
0.000.00%
Last trade - 00:00- €1.17bn
- €1.94bn
- €1.15bn
- 79
- 35
- 53
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.82 | ||
| PEG Ratio (f) | 2.45 | ||
| EPS Growth (f) | 5.99% | ||
| Dividend Yield (f) | 3.48% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.81 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 17.74 | ||
| Price to Sales | 1.01 | ||
| EV to EBITDA | 8.89 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.55% | ||
| Return on Equity | 5.26% | ||
| Operating Margin | 9.28% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 837.26 | 1,025.32 | 1,129.74 | 1,187.66 | 1,153.99 | 1,190.59 | 1,223.18 | 9.12% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -12.07 | +0.59 | +36.37 | -17.03 | +10.16 | +5.7 | +7.06 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CompuGroup Medical SE & Co. KGaA is a Germany-based company engaged in the enterprise software development. The Company focuses on providing software solutions to healthcare institutions. The activities are divided into six segments: Ambulatory Software Services (AIS), providing practice management software and medical records; Pharmacy Information Systems (PCS), including integrated clinical, administrative and financial software applications for pharmacies; Hospital Information Systems (HIS), such as laboratory and special care information systems; Communication & Data (C&D), offering software interfaces for pharmaceutical and medical equipment manufacturers; provides Picture Archiving and Communication Systems (PACS); Workflow & Decision Support (WDS), delivering software for management support aimed at healthcare payers, such as health insurers and managed care companies, and Internet Service Provider (ISP), providing Internet for healthcare providers.
Directors
- Philip von Ilberg CSU (58)
- Dirk Woessner CMG (52)
- Sven Thomas Mueller VSU (42)
- Michael Rauch CFO (49)
- Frank Brecher CTO (52)
- Ralph Korfgen MDR (55)
- Eckart Pech MDR (52)
- Hannes Reichl MDR (45)
- Claudia Frevel SUB (56)
- Michael Fuchs SUB (72)
- Ulrike Handel SUB (50)
- Ursula Keller SUB (55)
- Martin Koehrmann SUB (47)
- Volker Kohl SUB (50)
- Julia Mole SUB (33)
- Matthias Stoermer SUB (56)
- Bettina Volkens SUB (57)
- Andreas Wiese SUB (55)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 18th, 2020
- Public Since
- May 4th, 2007
- No. of Employees
- 8,712
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- XETRA
- Shares in Issue
- 51,734,576
- Address
- Maria Trost 21, KOBLENZ, 56070
- Web
- https://www.cgm.com/
- Phone
- +49 26180000
- Contact
- Claudia Thome
- Auditors
- KPMG AG Wirtschaftsprufungsgesellschaft
Upcoming Events for COP
CompuGroup Medical SE & Co KgaA Annual Shareholders Meeting
Q2 2025 CompuGroup Medical SE & Co KgaA Earnings Release
Dividend For COP1n.DE - 0.0500 EUR
Similar to COP
FAQ
What is the CompuGroup Medical SE & Co KgaA share price?
As of Today at 01:01 UTC, shares in CompuGroup Medical SE & Co KgaA are trading at €22.62. This share price information is delayed by 15 minutes.
How has the CompuGroup Medical SE & Co KgaA share price performed this year?
Shares in CompuGroup Medical SE & Co KgaA last closed at €22.62 and the price had moved by -18.52% over the past 365 days. In terms of relative price strength the CompuGroup Medical SE & Co KgaA share price has underperformed the FTSE Global All Cap Index by -25.01% over the past year.
What are the analyst and broker recommendations for CompuGroup Medical SE & Co KgaA?
The overall consensus recommendation for CompuGroup Medical SE & Co KgaA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the CompuGroup Medical SE & Co KgaA dividend yield?
The CompuGroup Medical SE & Co KgaA dividend yield is 0.22% based on the trailing twelve month period.
Does CompuGroup Medical SE & Co KgaA pay a dividend?
Last year, CompuGroup Medical SE & Co KgaA paid a total dividend of €0.05, and it currently has a trailing dividend yield of 0.22%.Looking ahead, shares in CompuGroup Medical SE & Co KgaA are due to go ex-dividend on 2025-08-04 and the next dividend pay date is 2025-08-06.
When does CompuGroup Medical SE & Co KgaA next pay dividends?
CompuGroup Medical SE & Co KgaA are due to go ex-dividend on 2025-08-04 and the next dividend pay date is 2025-08-06. The historic dividend yield on CompuGroup Medical SE & Co KgaA shares is currently 0.22%.
How do I buy CompuGroup Medical SE & Co KgaA shares?
To buy shares in CompuGroup Medical SE & Co KgaA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CompuGroup Medical SE & Co KgaA?
As of the previous close price of €22.62, shares in CompuGroup Medical SE & Co KgaA had a market capitalisation of €1.17bn.
Where are CompuGroup Medical SE & Co KgaA shares listed?
Here are the trading details for CompuGroup Medical SE & Co KgaA:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: COP
What kind of share is CompuGroup Medical SE & Co KgaA?
Based on an overall assessment of its quality, value and momentum CompuGroup Medical SE & Co KgaA is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CompuGroup Medical SE & Co KgaA share price forecast for 2025?
The analyst consensus target price for shares in CompuGroup Medical SE & Co KgaA is €20.90. That is 7.6% below the last closing price of €22.62.
Analysts covering CompuGroup Medical SE & Co KgaA currently have a consensus Earnings Per Share (EPS) forecast of €1.61 for the next financial year.
Find out moreWhat is the trend in the CompuGroup Medical SE & Co KgaA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CompuGroup Medical SE & Co KgaA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +50.48%.
As of the last closing price of €22.62, shares in CompuGroup Medical SE & Co KgaA were trading +21.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CompuGroup Medical SE & Co KgaA PE Ratio?
The CompuGroup Medical SE & Co KgaA PE ratio based on its reported earnings over the past 12 months is 13.82. The shares last closed at €22.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CompuGroup Medical SE & Co KgaA?
CompuGroup Medical SE & Co KgaA's management team is headed by:
- Philip von Ilberg - CSU
- Dirk Woessner - CMG
- Sven Thomas Mueller - VSU
- Michael Rauch - CFO
- Frank Brecher - CTO
- Ralph Korfgen - MDR
- Eckart Pech - MDR
- Hannes Reichl - MDR
- Claudia Frevel - SUB
- Michael Fuchs - SUB
- Ulrike Handel - SUB
- Ursula Keller - SUB
- Martin Koehrmann - SUB
- Volker Kohl - SUB
- Julia Mole - SUB
- Matthias Stoermer - SUB
- Bettina Volkens - SUB
- Andreas Wiese - SUB